DNA ENCODING A HUMAN RECEPTOR (HP15A) AND USES THEREOF

Details for Australian Patent Application No. 2002357337 (hide)

Owner SYNAPTIC PHARMACEUTICAL CORPORATION

Inventors SMITH, Kelli, E.; WEINSHANK, Richard

Pub. Number AU-A-2002357337

PCT Number PCT/US02/40612

PCT Pub. Number WO2003/054540

Priority 10/029,436 19.12.01 US

Filing date 19 December 2002

Wipo publication date 9 July 2003

International Classifications

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 015/00 Mutation or genetic engineering

C12N 015/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 10/029,436 19.12.01 US

2 October 2003 Application Open to Public Inspection

  Published as AU-A-2002357337

2 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357338-METHODS FOR IMPROVING FILTRATION PERFORMANCE OF HOLLOW FIBER MEMBRANES

2002357336-METHOD AND SYSTEM FOR ASSET TRANSITION QUALITY CONTROL